×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Brain Cancer

Feature Video
Watch a video about Chad, a patient using Optune.
Learn how Chad manages his treatment while enjoying his favorite activities.
Kristie L. Kahl
Berubicin showed promise in the treatment of glioblastoma as a drug that was able to cross the blood-brain barrier.
Samira Rajabi
When stuck in this space, it is tempting to hide from life, but with all the beauty in the world, it doesn't serve any of us to hide.
Thea's Star of Hope
When asked about her favorite thing about Thea's Star of Hope, the ten-year-old explained that the organization is like a laser on pediatric brain tumors, shooting at them until, hopefully one day, poof! They disappear.
Kristie L. Kahl
Following fertility clinic malfunctions in Cleveland and San Francisco, many patients who have or had cancer are facing devastating losses, leaving many questions in the wake of these events.
Katie Kosko
Findings from an early phase clinical trial that used a so-called “smart bomb” virus — which was altered to attack tumor cells rather than normal cells — appeared to show promise in this area.
Kristie L. Kahl
Researchers from Texas A&M University found that circadian rhythms may be key in the timing of when chemotherapy is administered to patients with glioblastoma.
NATE BILINSKI
After being diagnosed with glioblastoma, experimental immunotherapy saved his life.
Samira Rajabi
It's hard to stop comparing our sick bodies to the people around us, but once we do, as both patients and caretakers, we learn to honor our own experiences and value ourselves in new and beautiful ways.
Kristie L. Kahl
In recent years, major advances have been made in the immunotherapy scape, as it has become instrumental in revolutionizing the way oncologists treat a variety of cancers. However, its success in patients with brain cancer has been extremely limited.
Brielle Urciuoli
While causes for pneumonia were varied – including bacteria (14 percent), virus (22 percent) and unspecified (64 percent) – the majority of children did not have immune deficiencies recorded at the time of their pneumonia diagnosis.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other